|
2003 Journal Article Biological properties and therapeutic potential of billirubinMcGeary, R. P., Szyczew, A. J. and Toth, I. (2003). Biological properties and therapeutic potential of billirubin. Mini Reviews in Medicinal Chemistry, 3 (3), 253-256. doi: 10.2174/1389557033488213 |
|
2003 Conference Publication Liposaccharide delivery system: Application for peptide IT-100, LHRH and conotoxin MIIBlanchfield, J. T., Chan, Y., Rhee, H., Alewood, P.F., Adams, D. J. and Toth, I. (2003). Liposaccharide delivery system: Application for peptide IT-100, LHRH and conotoxin MII. 18th American Peptide Symposium, Boston, USA, 19-23 July, 2003. HOBOKEN: JOHN WILEY & SONS INC. |
|
2003 Journal Article Lipid and carbohydrate based adjuvant/carriers in immunologyMcGeary, R. P., Olive, C. and Toth, I. (2003). Lipid and carbohydrate based adjuvant/carriers in immunology. Journal of Peptide Science, 9 (7), 405-418. doi: 10.1002/psc.467 |
|
2003 Book Chapter Introduction: A breakthrough in modern drug researchKeri, G. and Toth, I. (2003). Introduction: A breakthrough in modern drug research. Molecular Pathomechanisms and New Trends in Drug Research. (pp. 1-4) edited by G. Keri and I. Toth. London & New York: Taylor & Francis. |
|
2003 Conference Publication Liposacchride delivery system: Application to peptides conotoxin MII and endomorphin IBlanchfield, J. T., Gallagher, O. P., Koda, Y. and Toth, I. (2003). Liposacchride delivery system: Application to peptides conotoxin MII and endomorphin I. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 Nov, 2003. |
|
2003 Journal Article PrefaceToth, Istvan (2003). Preface. Mini-Reviews in Medicinal Chemistry, 3 (7), I-I. doi: 10.2174/1389557033487764 |
|
2003 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. 26th Australian Polymer Symposium, Noosa, Queensland, 13-17 July 2003. Australia: Royal Australian Chemical Institute. |
|
2003 Conference Publication Vaccine design against streptococcal infectionToth, I, Horvath, A, Olive, C and Good, MF (2003). Vaccine design against streptococcal infection. 18th American Peptide Symposium, Boston Ma, Jul 19-23, 2003. HOBOKEN: JOHN WILEY & SONS INC. |
|
2003 Conference Publication Use of synthetic dendrimer peptide's to mediate the delivery of a sense oligonucleotideMarano, R. J., Wimmer, N., Kearns, P. S., Thomas, B. G., Toth, I., Wilson, A. S., Brankov, M. and Rakoczy, P. E. (2003). Use of synthetic dendrimer peptide's to mediate the delivery of a sense oligonucleotide. Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology, Ft Lauderdale Florida, May, 2003. Rockville, MD United States: Association for Research in Vision and Ophthalmology. |
|
2003 Journal Article A new principle for tight junction modulation based on occludin peptidesTavelin, S., Hashimoto, K., Malkinson, J., Lazorova, L., Toth, I. and Artursson, P. (2003). A new principle for tight junction modulation based on occludin peptides. Molecular Pharmacology, 64 (6), 1530-1540. doi: 10.1124/mol.64.6.1530 |
|
2003 Journal Article Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failureRussell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S. and Molenaar, P. (2003). Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. American Journal of Physiology - Heart & Circulatory Physiology, 285 (Oct.2003), H1576-H1581. doi: 10.1152/ajpheart.00217.2003 |
|
2003 Book Chapter Drug delivery systems utilizing lipids and sugarsWong, A., Bender, V. and Toth, I. (2003). Drug delivery systems utilizing lipids and sugars. Molecular Pathomechanisms and New Trends in Drug Research. (pp. 599-612) edited by G. Keri and I. Toth. London & New York: Taylor & Francis. doi: 10.1201/9780203219973.ch45 |
|
2003 Conference Publication Lipid and carbohydrate based macromolecules in drug and vaccine deliveryToth, I., Horvath, A., Blanchfield, J. T., Olive, C., Good, M. F., Wimmer, N. and Rakoczy, E. P. (2003). Lipid and carbohydrate based macromolecules in drug and vaccine delivery. Brisbane Biological and Organic Chemistry Symposium, Gold Coast, 28 November, 2003. |
|
2002 Journal Article Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotidesWimmer, Norbert, Marano, Robert J., Kearns, Phillip S., Rakoczy, Elizabeth P. and Toth, Istvan (2002). Syntheses of polycationic dendrimers on lipophilic peptide core for complexation and transport of oligonucleotides. Bioorganic and Medicinal Chemistry Letters, 12 (18), 2635-2637. doi: 10.1016/S0960-894X(02)00511-5 |
|
2002 Journal Article Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analoguesWong, AK, Ross, BP, Chan, YN, Artursson, P, Lazorova, L, Jones, A and Toth, I (2002). Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. European Journal of Pharmaceutical Sciences, 16 (3), 113-118. doi: 10.1016/S0928-0987(02)00078-7 |
|
2002 Journal Article A lipid core peptide construct containing a conserved region determinant of the group a streptococcal M protein elicits heterologous opsonic antibodiesOlive, Colleen, Batzloff, Michael R., Horvath, Aniko, Wong, Allan, Clair, Timothy, Yarwood, Penny, Toth, Istvan and Good, Michael F. (2002). A lipid core peptide construct containing a conserved region determinant of the group a streptococcal M protein elicits heterologous opsonic antibodies. Infection And Immunity, 70 (5), 2734-2738. doi: 10.1128/IAI.70.5.2734-2738.2002 |
|
2002 Conference Publication Modify the bioactive to increase the availability and potency of a drug: Lipids and sugars in drug delivery and vaccine developmentBlanchfield, J. T. and Toth, I. (2002). Modify the bioactive to increase the availability and potency of a drug: Lipids and sugars in drug delivery and vaccine development. 8th International Pacific Rim Biotechnology Conference, Auckland, NZ, 17-20 Nov. 2002. |
|
2002 Other Outputs Charged liposaccarides for drug deliveryToth, I. and Falconer, R. A. (2002). Charged liposaccarides for drug delivery. UK-0100115.5; WO2002-AUS-20020103. |
|
2002 Journal Article Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technologyHayman, W. A., Toth, I., Flinn, N., Scanlon, M. and Good, M. F. (2002). Enhancing the immunogenicity and modulating the fine epitope recognition of antisera to a helical group A streptococcal peptide vaccine candidate from the M protein using lipid-core peptide technology. Immunology And Cell Biology, 80 (2), 178-187. doi: 10.1046/j.1440-1711.2002.01067.x |
|
2002 Book Chapter Lipoamino acid based glycoconjugates for peptide and drug deliveryFalconer, Robert A. and Toth, Istvan (2002). Lipoamino acid based glycoconjugates for peptide and drug delivery. Peptides for the New Millennium. (pp. 77-78) Dordrecht, The Netherlands: Kluwer Academic Publishers. doi: 10.1007/0-306-46881-6_310 |
